Study finds no link between DMTs and Covid-19 severity
Source: Centers for Disease Control and Prevention – Stay Healthy, Stay Home and Wash Your Hands Click HERE to…
Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis
Stay Healthy, Stay Home and Wash Your Hands Click HERE to Subscribe for the MS Beacon Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Press Release…
Stuart Schlossman
What is the Future of MS Therapy? Neuroprotection, and Blurred Lines Between Disease Phenotypes
When Ben Greenberg, MD, MPH, was asked to present a talk for the 2020 Consortium of Multiple Sclerosis Centers (CMSC)…
Stuart Schlossman
Siponimod Reduces Risk of Disability Progression Regardless of Prior Relapses in MS
Data from the phase 3 EXPAND clinical trial (NCT01665144) of siponimod (Mayzent; Novartis) demonstrated the treatment’s ability to reduce the…
Stuart Schlossman
BACK Novartis builds case for MS drug ofatumumab as FDA decision looms
Click HERE to Subscribe for the MS Beacon Newsletter May 27, 2020 Novartis has reported new data with its multiple…
Stuart Schlossman
Ofatumumab Increases NEDA-3 ( no evidence of disease activity) Likelihood in MS, Compared With Teriflunomide
Novartis’s anti-CD20 monoclonal antibody has been shown to increase the odds of patients with multiple sclerosis achieving no evidence of…
Stuart Schlossman
Amid the COVID-19 Pandemic, Neurologists in Canada Report Pulling Back from EMD Serono’s Mavenclad and Sanofi Genzyme’s Lemtrada, While Roche’s Ocrevus Stalls, According to Spherix Global Insights
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
Long-Term Data Show Sustained Benefit of Siponimod (Mayzent) for Secondary Progressive MS
Click HERE to Subscribe for the MS Beacon Newsletter Jennifer Barrett April 22, 2020 Siponimod (Mayzent, Novartis) had a sustained…
Stuart Schlossman
Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…
Stuart Schlossman
Having MS does not make you Immune Compromised — The Use however of certain Disease Modifying Therapies (DMT’s), Can or Will make you Immunocomprised..
COVID-19 is unprecedented and a rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay…
Stuart Schlossman
